Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant.

Neggers, S J C M M; van Aken, M O; de Herder, W W; Feelders, R A; Janssen, J A M J L; Badia, X; Webb, S M; van der Lely, A J

Neggers, S J C M M; van Aken, M O; de Herder, W W; Feelders, R A; Janssen, J A M J L; Badia, X; Webb, S M; van der Lely, A J.

Affiliation

Neggers SJ; Department of Internal Medicine, Erasmus University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands. s.neggers@erasmusmc.nl

J Clin Endocrinol Metab ; 93(10): 3853-9, 2008 Oct.

Article in En | MEDLINE | ID: mdl-18647806

Subject(s)

Acromegaly/drug therapy; Hormone Antagonists/administration & dosage; Human Growth Hormone/analogs & derivatives; Quality of Life; Somatostatin/analogs & derivatives; Acromegaly/psychology; Adult; Aged; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Hormone Antagonists/adverse effects; Human Growth Hormone/administration & dosage; Human Growth Hormone/adverse effects; Humans; Male; Middle Aged; Placebos; Somatostatin/administration & dosage; Somatostatin/adverse effects; Time Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Acromegaly / Somatostatin / Human Growth Hormone / Hormone Antagonists Type of study: Clinical_trials / Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2008 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google